Cargando…

The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study

BACKGROUND: As of August 25, 2021, Jiangsu province experienced the largest COVID-19 outbreak in eastern China that was seeded by SARS-CoV-2 Delta variants. As one of the key epidemiological parameters characterizing the transmission dynamics of COVID-19, the incubation period plays an essential rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kai, Luan, Zemin, Guo, Zihao, Ran, Jinjun, Tian, Maozai, Zhao, Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678331/
https://www.ncbi.nlm.nih.gov/pubmed/36346940
http://dx.doi.org/10.2196/40751
_version_ 1784833969286545408
author Wang, Kai
Luan, Zemin
Guo, Zihao
Ran, Jinjun
Tian, Maozai
Zhao, Shi
author_facet Wang, Kai
Luan, Zemin
Guo, Zihao
Ran, Jinjun
Tian, Maozai
Zhao, Shi
author_sort Wang, Kai
collection PubMed
description BACKGROUND: As of August 25, 2021, Jiangsu province experienced the largest COVID-19 outbreak in eastern China that was seeded by SARS-CoV-2 Delta variants. As one of the key epidemiological parameters characterizing the transmission dynamics of COVID-19, the incubation period plays an essential role in informing public health measures for epidemic control. The incubation period of COVID-19 could vary by different age, sex, disease severity, and study settings. However, the impacts of these factors on the incubation period of Delta variants remains uninvestigated. OBJECTIVE: The objective of this study is to characterize the incubation period of the Delta variant using detailed contact tracing data. The effects of age, sex, and disease severity on the incubation period were investigated by multivariate regression analysis and subgroup analysis. METHODS: We extracted contact tracing data of 353 laboratory-confirmed cases of SARS-CoV-2 Delta variants’ infection in Jiangsu province, China, from July to August 2021. The distribution of incubation period of Delta variants was estimated by using likelihood-based approach with adjustment for interval-censored observations. The effects of age, sex, and disease severity on the incubation period were expiated by using multivariate logistic regression model with interval censoring. RESULTS: The mean incubation period of the Delta variant was estimated at 6.64 days (95% credible interval: 6.27-7.00). We found that female cases and cases with severe symptoms had relatively longer mean incubation periods than male cases and those with nonsevere symptoms, respectively. One-day increase in the incubation period of Delta variants was associated with a weak decrease in the probability of having severe illness with an adjusted odds ratio of 0.88 (95% credible interval: 0.71-1.07). CONCLUSIONS: In this study, the incubation period was found to vary across different levels of sex, age, and disease severity of COVID-19. These findings provide additional information on the incubation period of Delta variants and highlight the importance of continuing surveillance and monitoring of the epidemiological characteristics of emerging SARS-CoV-2 variants as they evolve.
format Online
Article
Text
id pubmed-9678331
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-96783312022-11-22 The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study Wang, Kai Luan, Zemin Guo, Zihao Ran, Jinjun Tian, Maozai Zhao, Shi JMIR Public Health Surveill Original Paper BACKGROUND: As of August 25, 2021, Jiangsu province experienced the largest COVID-19 outbreak in eastern China that was seeded by SARS-CoV-2 Delta variants. As one of the key epidemiological parameters characterizing the transmission dynamics of COVID-19, the incubation period plays an essential role in informing public health measures for epidemic control. The incubation period of COVID-19 could vary by different age, sex, disease severity, and study settings. However, the impacts of these factors on the incubation period of Delta variants remains uninvestigated. OBJECTIVE: The objective of this study is to characterize the incubation period of the Delta variant using detailed contact tracing data. The effects of age, sex, and disease severity on the incubation period were investigated by multivariate regression analysis and subgroup analysis. METHODS: We extracted contact tracing data of 353 laboratory-confirmed cases of SARS-CoV-2 Delta variants’ infection in Jiangsu province, China, from July to August 2021. The distribution of incubation period of Delta variants was estimated by using likelihood-based approach with adjustment for interval-censored observations. The effects of age, sex, and disease severity on the incubation period were expiated by using multivariate logistic regression model with interval censoring. RESULTS: The mean incubation period of the Delta variant was estimated at 6.64 days (95% credible interval: 6.27-7.00). We found that female cases and cases with severe symptoms had relatively longer mean incubation periods than male cases and those with nonsevere symptoms, respectively. One-day increase in the incubation period of Delta variants was associated with a weak decrease in the probability of having severe illness with an adjusted odds ratio of 0.88 (95% credible interval: 0.71-1.07). CONCLUSIONS: In this study, the incubation period was found to vary across different levels of sex, age, and disease severity of COVID-19. These findings provide additional information on the incubation period of Delta variants and highlight the importance of continuing surveillance and monitoring of the epidemiological characteristics of emerging SARS-CoV-2 variants as they evolve. JMIR Publications 2022-11-18 /pmc/articles/PMC9678331/ /pubmed/36346940 http://dx.doi.org/10.2196/40751 Text en ©Kai Wang, Zemin Luan, Zihao Guo, Jinjun Ran, Maozai Tian, Shi Zhao. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 18.11.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Wang, Kai
Luan, Zemin
Guo, Zihao
Ran, Jinjun
Tian, Maozai
Zhao, Shi
The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study
title The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study
title_full The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study
title_fullStr The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study
title_full_unstemmed The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study
title_short The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study
title_sort association between clinical severity and incubation period of sars-cov-2 delta variants: retrospective observational study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678331/
https://www.ncbi.nlm.nih.gov/pubmed/36346940
http://dx.doi.org/10.2196/40751
work_keys_str_mv AT wangkai theassociationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT luanzemin theassociationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT guozihao theassociationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT ranjinjun theassociationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT tianmaozai theassociationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT zhaoshi theassociationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT wangkai associationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT luanzemin associationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT guozihao associationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT ranjinjun associationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT tianmaozai associationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy
AT zhaoshi associationbetweenclinicalseverityandincubationperiodofsarscov2deltavariantsretrospectiveobservationalstudy